• SARS-COV-2 Nucleocapsid (B.1.1.529/Omicron) protein (Recombinant) (C-His) (STJP001478)
  • SARS-COV-2 Nucleocapsid (B.1.1.529/Omicron) protein (Recombinant) (C-His) (STJP001478)
  • SARS-COV-2 Nucleocapsid (B.1.1.529/Omicron) protein (Recombinant) (C-His) (STJP001478)
  • SARS-COV-2 Nucleocapsid (B.1.1.529/Omicron) protein (Recombinant) (C-His) (STJP001478)

SARS-COV-2 Nucleocapsid (B.1.1.529/Omicron) protein (Recombinant) (C-His) (STJP001478)

SKU:
STJP001478-100

Shipping:
Free Shipping
Current Stock:
Host: E. coli
Reactivity: SARS-CoV-2
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Recombinant-SARS-COV-2 Nucleocapsid (B.1.1.529/Omicron)-C-His protein was developed from e. coli and has a target region of C-His. For use in research applications.
Formulation: Supplied as a 0.22 Mu m filtered solution in 20mM TRIS, 500mM NaCl, 0.1mM EDTA, 10% Glycerol, pH8.0.
Immunoreactivity: Measured by its binding ability in a functional ELISA. Immobilized SARS-CoV-2 Envelope at 2 Mu g/mL (100 Mu L/well) can bind SARS-COV-2 Nucleocapsid with a linear range of 0.2-65 ng/mL.
Immunogen: Recombinant SARS-COV-2 Nucleocapsid (B.1.1.529/Omicron) Protein is produced by E. coli expression system. The target protein is expressed with sequence (Ser2-Ala419 (P13L, E31del, R32del, S33del, R203K, G204R) ) of sars-cov-2 N (B.1.1.529/Omicron) (A
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance